Long-term maintenance of SVR in difficult-to-treat HCV genotypes in liver transplant recipients with HCV recurrence

被引：0

作者：

Ponziani, Francesca Romana ^{[1
]}

Milani, Alessandro ^{[1
]}

Gasbarrini, Antonio ^{[1
]}

Zaccaria, Raffaella ^{[1
]}

Vigano, Raffaella ^{[2
]}

Iemmolo, Rosa Maria ^{[3
]}

Donato, Maria F. ^{[4
]}

Rendina, Maria ^{[5
]}

Toniutto, Pierluigi ^{[6
]}

Pasulo, Luisa ^{[7
]}

Morelli, Maria Cristina ^{[8
]}

Burra, Patrizia ^{[9
]}

Miglioresi, Lucia ^{[10
]}

Merli, Manuela ^{[11
]}

Di Paolo, Daniele ^{[12
]}

Fagiuoli, Stefano ^{[7
]}

Pompili, Maurizio ^{[1
]}

机构：

[1] A Gemelli Hosp, Rome, Italy

[2] Osped Niguarda Ca Granda, Milan, Italy

[3] Univ Modena, I-41100 Modena, Italy

[4] Maggiore Hosp, Milan, Italy

[5] Univ Bari, Bari, Italy

[6] Univ Udine, I-33100 Udine, Italy

[7] Osped Riuniti Bergamo, I-24100 Bergamo, Italy

[8] St Orsola Malpighi Hosp, Bologna, Italy

[9] Univ Padua, Padua, Italy

[10] San Camillo Spallanzani Hosp, Rome, Italy

[11] Univ Roma La Sapienza, Rome, Italy

[12] Torvergata Univ, Rome, Italy

来源：

HEPATOLOGY | 2012年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1743

引用

页码：1004A / 1004A

页数：1

共 50 条

[21] Long term renal safety of HCV direct acting antivirals in HCV positive kidney transplant recipients
Rendina, M.
Paoletti, E.
Labarile, N.
Bussalino, E.
Marra, A.
Mocka, S.
Schena, A.
Castellaneta, A.
Castellaneta, N. M.
Barone, M.
Iannone, A.
Gesualdo, L.
Di Leo, A.
DIGESTIVE AND LIVER DISEASE, 2020, 52 : E22 - E22
[22] Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus (HCV) infection
Kuo, Alexander
Lan, Billy
Feng, Sandy
Terrault, Norah A.
HEPATOLOGY, 2006, 44 (04) : 189A - 189A
[23] Influence of hepatitis C virus (HCV) recurrence on quality of life (QOL) of long-term liver transplant survivors.
Patterson, DL
Singh, N
Wagner, MM
Gayowski, T
Marino, IR
TRANSPLANTATION, 1999, 67 (07) : S193 - S193
[24] Long-term impact of HCV on clinical outcomes and liver histology in kidney recipients.
Roth, D
Reddy, R
Kupin, W
Burke, G
Ciancio, G
Garces, G
Colona, J
Petrin, D
Miller, J
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 289 - 289
[25] LONG-TERM USE OF CALCINEURIN INHIBITORS IN DIFFICULT-TO-TREAT NEPHROTIC SYNDROME
Canpolat, Nur
Saygili, Seha Kamil
Kilicaslan, Isin
Tasdemir, Mehmet
Agbas, Ayse
Cicek, Rumeysa Yasemin
Arslan, Ishak
Caliskan, Salim
Sever, Lale
PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1931 - 1931
[26] Progression of Fibrosis in Maintenance Liver Transplant Recipients with HCV Recurrence Converted to Everolimus: Results of a Multicenter, Randomized, Controlled Study
Villamil, F.
Gadano, A.
Zingale, F.
Perez, R.
Gil, O.
Yantorno, S.
Mastai, R.
Otero, A.
Wang, Y.
Lopez, P.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 84 - 84
[27] LONG-TERM OUTCOME IN KIDNEY TRANSPLANT RECIPIENTS WITH HCV INFECTION WITH OR WITHOUT SUSTAINED VIROLOGIC RESPONSE
Goto, Norihiko
Futamura, Kenta
Tomosugi, Toshihide
Okada, Manabu
Tsujita, Makoto
Hiramitsu, Takahisa
Narumi, Shunji
Watarai, Yoshihiko
TRANSPLANT INTERNATIONAL, 2019, 32 : 120 - 120
[28] Does MMF really slow down fibrosis of HCV recurrence in liver transplant recipients?
Germani, Giacomo
Tsochatzis, Emmanuel
Burroughs, Andrew Kenneth
TRANSPLANT INTERNATIONAL, 2011, 24 (09) : E77 - E78
[29] Long Term Renal Function in Liver Transplant Recipients with HCV Infection - Impact of Gender and Nutritional Status
Veldt, Bart J.
Watt, Kymberly D.
Charlton, Michael R.
LIVER TRANSPLANTATION, 2010, 16 (06) : S131 - S131
[30] Steroid-free immunosupression results in decreased HCV recurrence in liver transplant recipients
Elias, N
Hertl, M
Kawai, T
Ko, DSC
Thiim, M
Chung, RT
Cosimi, AB
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 357 - 357

← 1 2 3 4 5 →